P12.01.B ANTI-VEGF TREATMENT EFFECT AGAINST GLIOMA IS IMMUNE DEPENDENT AND MEDIATED BY ENHANCED T CELL ACTIVITY
Cécile L. Maire(Dana-Farber Cancer Institute), K Lamszus(Universität Hamburg), Michael Spohn(Centre Hospitalier Universitaire de Clermont-Ferrand), Monika Westphal(Universität Hamburg), Malte Mohme(Universität Hamburg), Stefan H. Heinemann(Jena University Hospital), Jens Gempt(TUM Klinikum), Christian Casar(Universität Hamburg), Malik Alawi(Universität Hamburg), Eva Tolosa(Universitat Autònoma de Barcelona), Manfred T. Reetz(Chinese Academy of Sciences), Krystian Fita(Universität Hamburg)
Cited by 0
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Comprehensive molecular characterization of mitochondrial genomes in human cancers
|Nature Genetics|2020|520
Genomic instability in Gadd45a-deficient mice
|Nature Genetics|1999|517